Edition:
United States

Rexahn Pharmaceuticals Inc (RNN)

RNN on American Stock Exchange

0.46USD
26 Apr 2017
Change (% chg)

$0.01 (+2.51%)
Prev Close
$0.45
Open
$0.45
Day's High
$0.48
Day's Low
$0.45
Volume
3,855,933
Avg. Vol
5,027,631
52-wk High
$0.71
52-wk Low
$0.13

Select another date:

Thu, Apr 13 2017

BRIEF-Rexahn announces 1-for-10 reverse stock split

* Expects that reverse stock split will be effective on May 5, 2017 Source text for Eikon: Further company coverage:

BRIEF-Rexahn Pharma's cash and investments totaled about $20.3 mln as of Dec 31, 2016

* Rexahn Pharmaceuticals reports full year 2016 financial results and provides corporate update

BRIEF-Rexahn Pharmaceuticals announced update on safety, efficacy of RX-3117 in ongoing phase IIa clinical trial in metastatic pancreatic cancer

* Rexahn pharmaceuticals - announced update on safety and efficacy of rx-3117 in an ongoing phase IIa clinical trial in metastatic pancreatic cancer

BRIEF-Rexahn Pharmaceuticals reports Q3 loss per share of $0.01

* Rexahn Pharma - expects cash, investments as of Sept 30, 2016 to be sufficient to fund cash flow requirements for activities into first half of 2018

BRIEF-Rexahn Pharmaceuticals says received notice of allowance from U.S PTO

* Received notice of allowance from U.S PTO for a patent for claims related to synthesis of its novel anti-cancer investigational drug candidate, rx-3117 Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web